LEADER 02054nam  2200565Ia 450 
001 9910449793803321
005 20200520144314.0
010   $a1-280-28638-5
010   $a9786610286386
010   $a0-309-55238-9
035   $a(CKB)1000000000245254
035   $a(SSID)ssj0000240514
035   $a(PQKBManifestationID)11186237
035   $a(PQKBTitleCode)TC0000240514
035   $a(PQKBWorkID)10265992
035   $a(PQKB)10561142
035   $a(DNLM)101255897
035   $a(MiAaPQ)EBC3378029
035   $a(Au-PeEL)EBL3378029
035   $a(CaPaEBR)ebr10103978
035   $a(CaONFJC)MIL28638
035   $a(OCoLC)923275641
035   $a(EXLCZ)991000000000245254
100   $a20050825d2005      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aSafe medical devices for children$b[electronic resource] /$fCommittee on Postmarket Surveillance of Pediatric Medical Devices, Board on Health Sciences Policy ; Marilyn J. Field and Hugh Tilson, editors ; Institute of Medicine of the National Academies
205   $a1st ed.
210   $aWashington, D.C. $cNational Academies Press$dc2005
215   $axxi, 457 p
300   $a"This study was supported by Contract No. 223-01-2460, Task Order No. 11 between the National Academy of Sciences and the U.S. Food and Drug Administration."
311   $a0-309-09631-6 
606   $aPediatrics$xEquipment and supplies$xStandards$zUnited States
606   $aPediatrics$zUnited States$xEquipment and supplies$xEvaluation
608   $aElectronic books.
615  0$aPediatrics$xEquipment and supplies$xStandards
615  0$aPediatrics$xEquipment and supplies$xEvaluation.
676   $a362.198/92
701   $aField$b Marilyn J$g(Marilyn Jane)$0855032
701   $aTilson$b Hugh Hanna$0986739
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910449793803321
996   $aSafe medical devices for children$92255170
997   $aUNINA